1T-LSD: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Tags: mobile edit mobile web edit
 
Line 3: Line 3:
[[File:1T-LSD_structure.png|thumb|right|Chemical structure of 1T-LSD]]
[[File:1T-LSD_structure.png|thumb|right|Chemical structure of 1T-LSD]]


'''1T-LSD''' is a [[psychedelic]] compound that is structurally related to [[lysergic acid diethylamide]] (LSD). It belongs to the class of [[lysergamides]], which are known for their potent effects on the human [[central nervous system]].
'''1T-LSD''' is a [[psychedelic]] compound that is structurally related to [[lysergic acid diethylamide]] (LSD). It is part of a class of substances known as [[lysergamides]], which are derivatives of [[lysergic acid]]. 1T-LSD is known for its psychoactive effects, which are similar to those of LSD, but it is distinguished by the presence of a thiophene ring in its chemical structure.


== Chemical Structure ==
== Chemical Structure ==


1T-LSD is a derivative of LSD, with a modification at the 1-position of the [[indole]] ring. The chemical structure of 1T-LSD includes a [[thiophene]] ring, which distinguishes it from other lysergamides. This modification is believed to alter its [[pharmacokinetics]] and [[pharmacodynamics]], potentially affecting its potency and duration of action.
1T-LSD is chemically known as 1-thiophene-N,N-diethyllysergamide. The presence of the thiophene ring is a key differentiator from LSD, which contains an indole ring. This modification is believed to alter the compound's interaction with [[serotonin receptors]] in the brain, potentially leading to differences in its psychoactive effects.


== Pharmacology ==
== Pharmacology ==


1T-LSD acts primarily as a [[serotonin receptor]] agonist, particularly at the [[5-HT2A receptor]], which is thought to be responsible for its psychedelic effects. Like other psychedelics, 1T-LSD may induce alterations in [[perception]], [[mood]], and [[cognition]]. The exact [[mechanism of action]] of 1T-LSD is not fully understood, but it is believed to involve modulation of [[neurotransmitter]] systems in the brain.
1T-LSD acts primarily as a partial agonist at the [[5-HT2A receptor]], which is the main target for classical psychedelics. The interaction with this receptor is responsible for the hallucinogenic effects experienced by users. Like other lysergamides, 1T-LSD may also interact with other serotonin receptor subtypes, contributing to its complex effects on perception, mood, and cognition.


== Effects ==
== Effects ==


The effects of 1T-LSD are similar to those of LSD, including [[visual hallucinations]], [[synesthesia]], and changes in [[thought patterns]]. Users may experience a sense of [[euphoria]], [[spiritual insight]], or [[anxiety]] and [[paranoia]] depending on the dose and individual [[set and setting]]. The duration of effects can vary, but typically lasts between 6 to 12 hours.
The effects of 1T-LSD are similar to those of LSD, including altered sensory perception, changes in mood, and cognitive shifts. Users may experience visual hallucinations, a sense of euphoria, and altered time perception. The onset of effects typically occurs within 30 to 60 minutes after ingestion, with a duration of action lasting 6 to 12 hours.


== Legal Status ==
== Legal Status ==


The legal status of 1T-LSD varies by country. In some jurisdictions, it may be classified as a [[controlled substance]] due to its structural similarity to LSD and its potential for abuse. Researchers and policymakers continue to debate the legal implications of novel psychedelics like 1T-LSD.
The legal status of 1T-LSD varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to LSD and its psychoactive properties. In others, it may not be specifically scheduled, although it could still be subject to analogue laws that regulate substances similar to controlled drugs.


== Research ==
== Related Compounds ==


Research on 1T-LSD is limited, but it is of interest to scientists studying the therapeutic potential of psychedelics. Preliminary studies suggest that compounds like 1T-LSD could have applications in treating [[mental health disorders]] such as [[depression]], [[anxiety]], and [[post-traumatic stress disorder]] (PTSD). However, more research is needed to fully understand its safety and efficacy.
1T-LSD is part of a broader class of lysergamides, which includes other compounds such as [[1P-LSD]], [[ALD-52]], and [[ETH-LAD]]. These compounds share a common lysergic acid backbone but differ in their substituents, leading to variations in their pharmacological profiles and effects.


== Related Pages ==
== See Also ==


* [[Lysergic acid diethylamide]]
* [[Lysergic acid diethylamide]]
Line 31: Line 31:
* [[Serotonin receptor]]
* [[Serotonin receptor]]
* [[Hallucinogen]]
* [[Hallucinogen]]
== Related Pages ==
* [[Psychedelic research]]
* [[History of LSD]]
* [[Psychedelic therapy]]


[[Category:Psychedelic drugs]]
[[Category:Psychedelic drugs]]
[[Category:Lysergamides]]
[[Category:Lysergamides]]

Latest revision as of 03:45, 13 February 2025

1T-LSD[edit]

Chemical structure of 1T-LSD

1T-LSD is a psychedelic compound that is structurally related to lysergic acid diethylamide (LSD). It is part of a class of substances known as lysergamides, which are derivatives of lysergic acid. 1T-LSD is known for its psychoactive effects, which are similar to those of LSD, but it is distinguished by the presence of a thiophene ring in its chemical structure.

Chemical Structure[edit]

1T-LSD is chemically known as 1-thiophene-N,N-diethyllysergamide. The presence of the thiophene ring is a key differentiator from LSD, which contains an indole ring. This modification is believed to alter the compound's interaction with serotonin receptors in the brain, potentially leading to differences in its psychoactive effects.

Pharmacology[edit]

1T-LSD acts primarily as a partial agonist at the 5-HT2A receptor, which is the main target for classical psychedelics. The interaction with this receptor is responsible for the hallucinogenic effects experienced by users. Like other lysergamides, 1T-LSD may also interact with other serotonin receptor subtypes, contributing to its complex effects on perception, mood, and cognition.

Effects[edit]

The effects of 1T-LSD are similar to those of LSD, including altered sensory perception, changes in mood, and cognitive shifts. Users may experience visual hallucinations, a sense of euphoria, and altered time perception. The onset of effects typically occurs within 30 to 60 minutes after ingestion, with a duration of action lasting 6 to 12 hours.

Legal Status[edit]

The legal status of 1T-LSD varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to LSD and its psychoactive properties. In others, it may not be specifically scheduled, although it could still be subject to analogue laws that regulate substances similar to controlled drugs.

Related Compounds[edit]

1T-LSD is part of a broader class of lysergamides, which includes other compounds such as 1P-LSD, ALD-52, and ETH-LAD. These compounds share a common lysergic acid backbone but differ in their substituents, leading to variations in their pharmacological profiles and effects.

See Also[edit]

Related Pages[edit]